Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,408.50
(
-1.24%
)
US TECH 100
28,259.60
(
-0.34%
)
Dow Jones
49,526.17
(
-1.07%
)
Brent Oil
107.39
(
-0.08%
)
Bitcoin
76,698.37
(
-0.92%
)
News Focus
News Focus
Post# of 257580
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

dewophile

Send PM Follow Ignore
Followers 51
Posts 5537
Boards Moderated 0
Alias Born 07/19/2006

dewophile

Re: DewDiligence post# 66998

Sunday, 10/05/2008 9:26:15 PM

Sunday, October 05, 2008 9:26:15 PM

Post# of 257580
because interferon is likely to have better efficacy against viral strains resistant to polymerase and protease inhibitors
besides - how many oral agents and proven combinations do you think will be approved before IN-lambda makes it to market?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today